Standout Papers

Blood pressure lowering for prevention of cardiovascular disea... 2009 2026 2014 2020 2.1k
  1. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis (2015)
    Dena Ettehad, Connor A. Emdin et al. The Lancet
  2. Severe Hypoglycemia and Risks of Vascular Events and Death (2010)
    Sophia Zoungas, Anushka Patel et al. New England Journal of Medicine
  3. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis (2012)
    Caroline S. Fox, Kunihiro Matsushita et al. The Lancet
  4. Intensive glucose control and macrovascular outcomes in type 2 diabetes (2009)
    Fiona Turnbull, Carlos Abraira et al. Diabetologia
  5. Albuminuria and Kidney Function Independently Predict Cardiovascular and Renal Outcomes in Diabetes (2009)
    Toshiharu Ninomiya, Vlado Perkovic et al. Journal of the American Society of Nephrology
  6. Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis (2010)
    Min Jun, Celine Foote et al. The Lancet
  7. Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis (2015)
    Xinfang Xie, Emily Atkins et al. The Lancet
  8. Effects of Intensive Blood Pressure Lowering on Cardiovascular and Renal Outcomes: A Systematic Review and Meta-Analysis (2012)
    Jicheng Lv, Alexander Bennett et al. PLoS Medicine
  9. Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomised pilot trial (2008)
    Craig S. Anderson, Yining Huang et al. The Lancet Neurology
  10. Effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: a meta-analysis of individual participant data from randomised controlled trials (2017)
    Sophia Zoungas, Hisatomi Arima et al. The Lancet Diabetes & Endocrinology

Immediate Impact

9 from Science/Nature 98 standout
Sub-graph 1 of 19

Citing Papers

Empagliflozin in Patients with Chronic Kidney Disease
2022 Standout
Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes
2021 Standout

Works of John Chalmers being referenced

Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis
2012 Standout
Albuminuria and Kidney Function Independently Predict Cardiovascular and Renal Outcomes in Diabetes
2009 Standout

Author Peers

Author Last Decade Papers Cites
John Chalmers 11920 9091 5163 5296 762 34.4k
L. Adrienne Cupples 8518 6814 4617 6436 536 42.3k
James R. Sowers 15126 14251 5321 6310 681 41.2k
Joost Dekker 8869 8735 6318 9678 887 51.6k
Lewis H. Kuller 19039 15696 10323 10797 999 76.0k
Hertzel C. Gerstein 12016 25805 5464 7930 496 49.6k
Alberto Zanchetti 33634 10242 2237 6965 819 44.3k
Suzanne Oparil 23662 10696 1991 5123 705 39.8k
Julie E. Buring 15309 12151 10461 10564 596 64.0k
Mary Cushman 21673 6773 12836 10339 755 55.3k
Lenore J. Launer 7305 3322 4288 2432 605 42.1k

All Works

Loading papers...

Rankless by CCL
2026